FDA Clearance Tracker · P080030-S026
iStent® Trabecular Mjcro-Bypass Stent System, Model GTS100
Last checked: Nov 20, 2026Latest source record: Mar 28, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Mar 28, 2024
Approved
Time to decision
175 days
Received Oct 5, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P080030-S026
- Device name
- iStent® Trabecular Mjcro-Bypass Stent System, Model GTS100
- Applicant
- Glaukos Corporation
- Applicant location
- Laguna Hills, CA
- Received
- Oct 5, 2023
- Decided
- Mar 28, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P080030
Device type
- Device type
- Intraocular pressure lowering implant (OGO)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Request for approval of labeling changes made to the Directions for Use and Package Insert.
Source documents
Other decisions for Glaukos Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K220032 · Decided Aug 2, 2022 · 209 days after receipt
Device type: Implant, Eye Valve (KYF) · Ophthalmology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.